Epicutaneous model of community-acquired Staphylococcus aureus skin infections

Infection and Immunity

Volumn 81, Issue 4, 2013, Pages 1306-1315

  Prabhakara, Ranjani ^a   Foreman, Oded ^b   De Pascalis, Roberto ^a   Lee, Gloria M ^a   Plaut, Roger D ^a   Kim, Stanley Y ^a   Stibitz, Scott ^a   Elkins, Karen L ^a   Merkel, Tod J ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ALLERGY TEST; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM ISOLATE; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXTERNAL AUDITORY CANAL; FEMALE; HOST; IMMUNE RESPONSE; INFLAMMATION; LYMPH NODE; MORROW BROWN ALLERGY TEST; MOUSE; NEEDLE; NEUTROPHIL; NONHUMAN; PREDICTION; PRIORITY JOURNAL; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TH1 CELL; TH17 CELL;

ANIMALS; BACTERIAL LOAD; COMMUNITY-ACQUIRED INFECTIONS; CYTOKINES; DISEASE MODELS, ANIMAL; EAR, EXTERNAL; FEMALE; LYMPH NODES; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICE, INBRED BALB C; NEUTROPHILS; SKIN; STAPHYLOCOCCAL SKIN INFECTIONS; TIME FACTORS;

EID: 84875536637     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01304-12     Document Type: Article

References (54)

1. Gordon RJ, Lowy FD. 2008. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin. Infect. Dis. 46(Suppl 5):S350-S359.
2. Otto M. 2010. Basis of virulence in community-associated methicillinresistant Staphylococcus aureus. Annu. Rev. Microbiol. 64:143-162.
3. Lowy FD. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532.
4. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763-1771.
5. Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, Leitch CD, Daum RS. 1998. Community-acquired methicillin- resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279:593-598.
6. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA. 2006. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355:666-674.
7. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, Johnson SK, Vandenesch F, Fridkin S, O'Boyle C, Danila RN, Lynfield R. 2003. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290:2976-2984.
8. Durupt F, Mayor L, Bes M, Reverdy ME, Vandenesch F, Thomas L, Etienne J. 2007. Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo. Br. J. Dermatol. 157:1161-1167.
9. Tkaczyk C, Hua L, Varkey R, Shi Y, Dettinger L, Woods R, Barnes A, MacGill RS, Wilson S, Chowdhury P, Stover CK, Sellman BR. 2012. Identification of anti-alpha toxin monoclonal antibodies that reduce the severity of Staphylococcus aureus dermonecrosis and exhibit a correlation between affinity and potency. Clin. Vaccine Immunol. 19:377-385.
10. Mesrati I, Saidani M, Ennigrou S, Zouari B, Ben RS. 2010. Clinical isolates of Pantone-Valentine leucocidin- and gamma-haemolysinproducing Staphylococcus aureus: prevalence and association with clinical infections. J. Hosp. Infect. 75:265-268.
11. Li M, Cheung GY, Hu J, Wang D, Joo HS, Deleo FR, Otto M. 2010. Comparative analysis of virulence and toxin expression of global community- associated methicillin-resistant Staphylococcus aureus strains. J. Infect. Dis. 202:1866-1876.
12. Kobayashi SD, Malachowa N, Whitney AR, Braughton KR, Gardner DJ, Long D, Bubeck WJ, Schneewind O, Otto M, Deleo FR. 2011. Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J. Infect. Dis. 204:937-941.
13. Cohen PR. 2007. Community-acquired methicillin-resistant Staphylococcus aureus skin infections: implications for patients and practitioners. Am. J. Clin. Dermatol. 8:259-270.
14. Gorwitz RJ. 2008. A review of community-associated methicillinresistant Staphylococcus aureus skin and soft tissue infections. Pediatr. Infect. Dis.J. 27:1-7.
15. Suchard JR. 2011. "Spider bite" lesions are usually diagnosed as skin and soft-tissue infections. J. Emerg. Med. 41:473-481.
16. Vozdecky C. 2009. Community-acquired methicillin-resistant Staphylococcus aureus: not just a spider bite. Fam. Community Health 32:76-84.
17. Francis JS, Doherty MC, Lopatin U, Johnston CP, Sinha G, Ross T, Cai M, Hansel NN, Perl T, Ticehurst JR, Carroll K, Thomas DL, Nuermberger E, Bartlett JG. 2005. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin. Infect. Dis. 40:100-107.
18. Zetola N, Francis JS, Nuermberger EL, Bishai WR. 2005. Communityacquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect. Dis. 5:275-286.
19. Hruz P, Zinkernagel AS, Jenikova G, Botwin GJ, Hugot JP, Karin M, Nizet V, Eckmann L. 2009. NOD2 contributes to cutaneous defense against Staphylococcus aureus through alpha-toxin-dependent innate immune activation. Proc. Natl. Acad. Sci. U. S. A. 106:12873-12878.
20. Molne L, Verdrengh M, Tarkowski A. 2000. Role of neutrophil leukocytes in cutaneous infection caused by Staphylococcus aureus. Infect. Immun. 68:6162-6167.
21. Kim MH, Granick JL, Kwok C, Walker NJ, Borjesson DL, Curry FR, Miller LS, Simon SI. 2011. Neutrophil survival and c-kit(+)-progenitor proliferation in Staphylococcus aureus-infected skin wounds promote resolution. Blood 117:3343-3352.
22. Rigby KM, Deleo FR. 2012. Neutrophils in innate host defense against Staphylococcus aureus infections. Semin. Immunopathol. 34:237-259.
23. Cho JS, Pietras EM, Garcia NC, Ramos RI, Farzam DM, Monroe HR, Magorien JE, Blauvelt A, Kolls JK, Cheung AL, Cheng G, Modlin RL, Miller LS. 2010. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J. Clin. Invest. 120:1762-1773.
24. Onunkwo CC, Hahn BL, Sohnle PG. 2010. Clearance of experimental cutaneous Staphylococcus aureus infections in mice. Arch. Dermatol. Res. 302:375-382.
25. Dai T, Tegos GP, Zhiyentayev T, Mylonakis E, Hamblin MR. 2010. Photodynamic therapy for methicillin-resistant Staphylococcus aureus infection in a mouse skin abrasion model. Lasers Surg. Med. 42:38-44.
26. Cho JS, Zussman J, Donegan NP, Ramos RI, Garcia NC, Uslan DZ, Iwakura Y, Simon SI, Cheung AL, Modlin RL, Kim J, Miller LS. 2011. Noninvasive in vivo imaging to evaluate immune responses and antimicrobial therapy against Staphylococcus aureus and USA300 MRSA skin infections. J. Investig. Dermatol. 131:907-915.
27. Bunce C, Wheeler L, Reed G, Musser J, Barg N. 1992. Murine model of cutaneous infection with gram-positive cocci. Infect. Immun. 60:2636-2640.
28. Demoly P, Bousquet J, Manderscheid JC, Dreborg S, Dhivert H, Michel FB. 1991. Precision of skin prick and puncture tests with nine methods. J. Allergy Clin. Immunol. 88:758-762.
29. Highlander SK, Hulten KG, Qin X, Jiang H, Yerrapragada S, Mason EO, Jr, Shang Y, Williams TM, Fortunov RM, Liu Y, Igboeli O, Petrosino J, Tirumalai M, Uzman A, Fox GE, Cardenas AM, Muzny DM, Hemphill L, Ding Y, Dugan S, Blyth PR, Buhay CJ, Dinh HH, Hawes AC, Holder M, Kovar CL, Lee SL, Liu W, Nazareth LV, Wang Q, Zhou J, Kaplan SL, Weinstock GM. 2007. Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus. BMC Microbiol. 7:99.
30. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, Lin F, Lin J, Carleton HA, Mongodin EF, Sensabaugh GF, Perdreau-Remington F. 2006. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367:731-739.
31. Loving CL, Khurana T, Osorio M, Lee GM, Kelly VK, Stibitz S, Merkel TJ. 2009. Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model. Infect. Immun. 77:255-265.
32. Meighen EA. 1991. Molecular biology of bacterial bioluminescence. Microbiol. Rev. 55:123-142.
33. Horinouchi S, Weisblum B. 1982. Nucleotide sequence and functional map of pC194, a plasmid that specifies inducible chloramphenicol resistance. J. Bacteriol. 150:815-825.
34. Atkins KL, Burman JD, Chamberlain ES, Cooper JE, Poutrel B, Bagby S, Jenkins AT, Feil EJ, van den Elsen JM. 2008. S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation. Mol. Immunol. 45:1600-1611.
35. Arnaud M, Chastanet A, Debarbouille M. 2004. New vector for efficient allelic replacement in naturally nontransformable, low-GC-content, gram-positive bacteria. Appl. Environ. Microbiol. 70:6887-6891.
36. Bruckner R. 1997. Gene replacement in Staphylococcus carnosus and Staphylococcus xylosus. FEMS Microbiol. Lett. 151:1-8.
37. Stemmer WP, Morris SK. 1992. Enzymatic inverse PCR: a restriction site independent, single-fragment method for high-efficiency, site-directed mutagenesis. Biotechniques 13:214-220.
38. Bubeck WJ, Patel RJ, Schneewind O. 2007. Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect. Immun. 75:1040-1044.
39. Kennedy AD, Bubeck WJ, Gardner DJ, Long D, Whitney AR, Braughton KR, Schneewind O, Deleo FR. 2010. Targeting of alphahemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J. Infect. Dis. 202:1050-1058.
40. Menzies BE, Kernodle DS. 1994. Site-directed mutagenesis of the alphatoxin gene of Staphylococcus aureus: role of histidines in toxin activity in vitro and in a murine model. Infect. Immun. 62:1843-1847.
41. Rauch S, DeDent AC, Kim HK, Bubeck WJ, Missiakas DM, Schneewind O. 2012. Abscess formation and alpha-hemolysin induced toxicity in a mouse model of Staphylococcus aureus peritoneal infection. Infect. Immun. 80:3721-3732.
42. Kreiswirth BN, Lofdahl S, Betley MJ, O'Reilly M, Schlievert PM, Bergdoll MS, Novick RP. 1983. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 305:709-712.
43. Bae T, Glass EM, Schneewind O, Missiakas D. 2008. Generating a collection of insertion mutations in the Staphylococcus aureus genome using bursa aurealis. Methods Mol. Biol. 416:103-116.
44. McNamara P. 2012. Genetic manipulation of Staphylococcus aureus, p 89-129. In J. A. Lindsay (ed), Staphylococcus: molecular genetics. Caister Academic Press, Norfolk, United Kingdom.
45. Doi K, Leelahavanichkul A, Yuen PS, Star RA. 2009. Animal models of sepsis and sepsis-induced kidney injury. J. Clin. Invest. 119:2868-2878.
46. Watkins RL, Pallister KB, Voyich JM. 2011. The SaeR/S gene regulatory system induces a pro-inflammatory cytokine response during Staphylococcus aureus infection. PLoS One 6:e19939. doi:10.1371/journal.pone .0019939.
47. Nakane A, Okamoto M, Asano M, Kohanawa M, Minagawa T. 1995. Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice. Infect. Immun. 63:1165-1172.
48. Joshi A, Pancari G, Cope L, Bowman E, Cua D, Proctor R, McNeely T. 2012. Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model. Hum. Vaccin. Immunother. 8:336-346.
49. Wei L, Laurence A, O'Shea JJ. 2008. New insights into the roles of Stat5a/b and Stat3 in T cell development and differentiation. Semin. Cell Dev. Biol. 19:394-400.
50. Siciliano NA, Skinner JA, Yuk MH. 2006. Bordetella bronchiseptica modulates macrophage phenotype leading to the inhibition of CD4+ T cell proliferation and the initiation of a Th17 immune response. J. Immunol. 177:7131-7138.
51. Mizuno T, Ando T, Nobata K, Tsuzuki T, Maeda O, Watanabe O, Minami M, Ina K, Kusugami K, Peek RM, Goto H. 2005. Interleukin-17 levels in Helicobacter pylori-infected gastric mucosa and pathologic sequelae of colonization. World J. Gastroenterol. 11:6305-6311.
52. Deleo FR, Diep BA, Otto M. 2009. Host defense and pathogenesis in Staphylococcus aureus infections. Infect. Dis. Clin. North Am. 23:17-34.
53. Mayer-Scholl A, Averhoff P, Zychlinsky A. 2004. How do neutrophils and pathogens interact? Curr. Opin. Microbiol. 7:62-66.
54. Roos D, van Bruggen R, Meischl C. 2003. Oxidative killing of microbes by neutrophils. Microbes Infect. 5:1307-1315.